News 30 Apr 2025 Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz
Scientific articles 29 Apr 2025 Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: A prospective, open-label, single-arm, Phase II–III, non-randomised study The Lancet Global Health
Scientific articles 29 Apr 2025 Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: A phase IIIb, prospective, open-label, non-randomised, cohort study The Lancet Global Health
News 25 Apr 2025 Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi
Press releases 24 Apr 2025 Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease
In the media 23 Apr 2025 Race against time: New treatment for deadly HIV complication enters trials Daily Nation
Press releases 23 Apr 2025 DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease
Scientific articles 21 Apr 2025 A balancing act: Navigating the advantages and challenges of pioneering mycetoma treatment in Sudan – A landmark trial by the Mycetoma Research Center PLOS Neglected Tropical Diseases
Scientific articles 17 Apr 2025 Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network The Lancet Child & Adolescent Health
In the media 17 Apr 2025 New treatment for deadly HIV-linked meningitis enters phase II trial The Standard
In the media 17 Apr 2025 Un nouveau traitement contre la méningite à cryptocoque, en phase d’essai RTS
In the media 16 Apr 2025 Accord historique à l’OMS sur la préparation et la lutte contre les futures pandémies AFP
In the media 16 Apr 2025 Luz verde para un “histórico” tratado mundial contra pandemias impulsado por la OMS El País
Press releases 4 Nov 2017 Phase II/III studies show high efficacy and safety of fexinidazole, the first oral treatment for sleeping sickness
Press releases 20 Sep 2017 DNDi welcomes Malaysia’s move to secure access to more affordable treatments for hepatitis C
Press releases 4 Sep 2017 More than EUR 56 million raised to fund initiative to fight antibiotic resistance
Press releases 31 Aug 2017 U.S. FDA approves Chemo Group’s benznidazole to treat children with Chagas disease
Press releases 8 Aug 2017 DNDi welcomes Dr Marie-Paule Kieny as new Chair of the Board of Directors with Prof. Marcel Tanner stepping down after ten successful years
Press releases 6 Jul 2017 Entasis Therapeutics and the Global Antibiotic Research & Development Partnership (GARDP) to develop a new treatment for drug-resistant gonorrhea
Press releases 6 Jun 2017 Child-friendly formulation of WHO-recommended HIV treatment now approved by the CDSCO
Press releases 3 May 2017 New open source project engages universities in neglected diseases drug discovery
Press releases 19 Apr 2017 Merck joins DNDi’s ‘Drug Discovery Booster’ to accelerate discovery of new treatments for neglected diseases
Press releases 13 Apr 2017 First large-scale survey of Chagas disease in the United States confirms that the “Silent Killer” is a major public health challenge for the country
Press releases 30 Mar 2017 Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Press releases 14 Feb 2017 Study confirms key therapeutic advance for children living with HIV and tuberculosis
Press releases 22 Oct 2016 African eye worm is worse than it looks: new study shows that the disease leads to increased mortality
Press releases 22 Sep 2016 Global Antibiotic Research & Development Partnership receives financial support from Swiss Government
